Related Experiment Video
Updated: May 8, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
[Clinical analysis of intrahepatic cholestasis of pregnancy]
Lei Li1, Xin-Yan Zhao, Xiao-Juan Ou
1Affiliated Hospital of Weifang Medical University, Weifang Shandong 261031, China.
Insights
Intrahepatic cholestasis of pregnancy (ICP) is manageable, with no increased mortality for mothers or infants. High bile acid levels may correlate with preterm birth, suggesting corticosteroids for fetal lung maturation.
Area of Science:
- Obstetrics and Gynecology
- Hepatology
- Neonatology
Background:
- Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder specific to pregnancy.
- Understanding ICP's clinical profile is crucial for effective management and improved outcomes.
Purpose of the Study:
- To systematically review and establish a comprehensive clinical profile of intrahepatic cholestasis of pregnancy (ICP).
- To analyze ICP cases managed at our institution, focusing on diagnosis, complications, management, and outcomes.
Main Methods:
- Retrospective collection and systematic review of clinical data from nine ICP cases.
- Analysis included diagnosis, maternal/infant complications, treatment strategies, and outcomes.
Main Results:
- Seven of nine ICP patients presented with pruritus; all had elevated bile acid levels.
- Complications included gestational hypertension, diabetes mellitus, and pre-eclampsia. All patients delivered via surgical means, with three preterm births.
- Maternal bile acid levels normalized post-delivery, and all infants survived without complications.
Conclusions:
- ICP does not elevate maternal or infant mortality rates, indicating a generally favorable prognosis.
- Elevated bile acid levels may correlate with the timing of preterm delivery; corticosteroids may aid fetal lung maturation.
- Severe ICP cases warrant induction of labor or Cesarean section; ursodeoxycholic acid is a suitable treatment for most cases.
Objective:
To generate a comprehensive clinical profile of intrahepatic cholestasis of pregnancy (ICP) by systematically reviewing ICP cases managed in our hospital.
Methods:
The recorded clinical data, including diagnosis, complications, management, and maternal and infant outcomes, of nine ICP cases were collected retrospectively and reviewed systematically.
Results:
Seven of the nine total ICP patients presented with pruritus. All nine of the ICP patients showed bile acid level beyond the normal range. ICP complications included gestational hypertension (n = 3), diabetes mellitus (DM, n = 1) and impaired glucose tolerance (IGT, n = 1), and pre-eclampsia (n = 1). The infant of one patient with severe ICP showed meconium-stained liquor. All nine of the ICP patients underwent surgical delivery, of which three were delivered preterm (between the 35th and 36th week of gestation). All mothers' total bile acids declined to normal levels after delivery, and all infants survived without complication.
Conclusion:
ICP does not increase the puerpera mortality rate and does not represent a poor prognosis for infants. Bile acid levels in the ICP patients, however, may be related to the extent of premature delivery time. While the standard drug treatment of ursodeoxycholic acid is suitable for most ICP cases, those with insufficient gestational age may benefit from adjuvant corticosteroid therapy to promote fetal lung maturation prior to preterm delivery. Severe ICP cases should be managed by inducing artificial labor or performing Caesarean section.
Related Concept Videos
Cholecystitis
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis I: Introduction

